SCHEMBL25150620

SCHEMBL25150620

CC(C)c1c(-c2ccccc2F)nn2ccc(N3CCCC3)nc12

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 1/20 0.41
▸ SMPD3 Q9NY59 4/20 0.39
▸ NPC1 O15118 1/20 0.37
▸ PDE10A Q9Y233 2/20 0.37
▸ KDM5B Q9UGL1 1/20 0.37
▸ HIF1A Q16665 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ NPY5R Q15761 1/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ PIM2 Q9P1W9 1/20 0.34
▸ MAT2A P31153 1/20 0.34
▸ MAPT P10636 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ AAK1 Q2M2I8 1/20 0.32
▸ SYK P43405 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25150576 0.90 SMPD3 (0.42) SMPD3NPC1KDM5BALDH1A1MAPT
SCHEMBL23013953 0.79 MAOB (0.40) MAOBSMPD3NPC1HIF1AMAT2A
SCHEMBL29703795 0.79 MAOB (0.40) MAOBSMPD3NPC1HIF1AMAT2A
SCHEMBL25150706 0.75 DGAT1 (0.45) NPC1ALDH1A1KDM4EGAAHPGD
SCHEMBL29939181 0.75 DGAT1 (0.45) NPC1ALDH1A1KDM4EGAAHPGD
SCHEMBL25150575 0.73 SMPD3 (0.42) SMPD3NPC1ALDH1A1TP53
SCHEMBL25150770 0.71 KDM5B (0.39) SMPD3PDE10AKDM5BHIF1A
SCHEMBL25150557 0.70 KDM5B (0.40) MAOBNPC1KDM5BALDH1A1KDM4E
SCHEMBL23014103 0.70 SMPD3 (0.41) SMPD3NPC1ALDH1A1KDM4EHPGD
SCHEMBL29703828 0.70 SMPD3 (0.41) SMPD3NPC1ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634425-B2 Pharmaceutical compounds PFIZER INC. (US) 2023-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11634425-B2 Pharmaceutical compounds GABRA6, CHRNA6, CNR1 MAOB 873/4885SMPD3 4665/4885NPC1 605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback